Zobrazeno 1 - 10
of 171
pro vyhledávání: '"Gerard A. Rongen"'
Autor:
Veroniek E. M. Harbers, Lilly G. J. M. Zwerink, Gerard A. Rongen, Willemijn M. Klein, Carine J. M. van derVleuten, Ingrid M. P. vanRijnsoever, Lynda Gerdsen‐Drury, Uta E. Flucke, Bas H. Verhoeven, Peter C. J. deLaat, Chantal M. A. M. van derHorst, Leo J. Schultze Kool, D. Maroeska W. M. teLoo
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 5, Pp 781-796 (2023)
Abstract The clinical presentation of patients with slow‐flow vascular malformations is very heterogeneous. High clinical burden and subsequent reduced health‐related quality of life is something they have in common. There is an unmet medical nee
Externí odkaz:
https://doaj.org/article/a55fba27e7964f5a87dd8702783b6dfe
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 19, Iss , Pp 100803- (2020)
Purpose: To report the long-term follow-up (12 years) of a 36-year-old male patient with crystalline keratopathy of both eyes, diagnosed with monoclonal gammopathy of undetermined significance (MGUS). Complete ophthalmic, systemic, and corneal immuno
Externí odkaz:
https://doaj.org/article/baaeca7772fe4dc39b9097c04adb7196
Publikováno v:
Physiological Reports, Vol 7, Iss 23, Pp n/a-n/a (2019)
Abstract Clinical data suggests that heart rate (HR) control with selective β1‐blockers may improve cardiac function during septic shock. However, it seems counterintuitive to start β‐blocker infusion in a shock state when organ blood flow is a
Externí odkaz:
https://doaj.org/article/6efac4fb7b5041e487d6df3bbb637107
Autor:
Gerard A. Rongen
Publikováno v:
EBioMedicine, Vol 2, Iss 9, Pp 1012-1013 (2015)
Externí odkaz:
https://doaj.org/article/dee5d854eca1492db014ffcdfeab973c
Allopurinol to reduce cardiovascular morbidity and mortality: A systematic review and meta-analysis.
Autor:
Karel H van der Pol, Kimberley E Wever, Mariette Verbakel, Frank L J Visseren, Jan H Cornel, Gerard A Rongen
Publikováno v:
PLoS ONE, Vol 16, Iss 12, p e0260844 (2021)
AimsTo compare the effectiveness of allopurinol with no treatment or placebo for the prevention of cardiovascular events in hyperuricemic patients.Methods and resultsPubmed, Web of Science and Cochrane library were searched from inception until July
Externí odkaz:
https://doaj.org/article/4677bfc6c5724f919b034d4faf8c67aa
Autor:
Marga Nijenhuis, Bianca Soree, Wafa O. M. Jama, Nienke J. de Boer-Veger, Anne Marie Buunk, Henk-Jan Guchelaar, Elisa J. F. Houwink, Gerard A. Rongen, Ron H. N. van Schaik, Jesse J. Swen, Daan Touw, Jan van der Weide, Roos van Westrhenen, Vera H. M. Deneer, Arne Risselada
Publikováno v:
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics. Nature Publishing Group
European Journal of Human Genetics
European Journal of Human Genetics. Nature Publishing Group
Pharmacogenetics (PGx) studies the effect of heritable genetic variation on drug response. Clinical adoption of PGx has remained limited, despite progress in the field. To promote implementation, the Dutch Pharmacogenetics Working Group (DPWG) develo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f755520f566484b90f85d4cb382e207
http://hdl.handle.net/1887/3515272
http://hdl.handle.net/1887/3515272
Autor:
Marga, Nijenhuis, Bianca, Soree, Wafa O M, Jama, Nienke J, de Boer-Veger, Anne Marie, Buunk, Henk-Jan, Guchelaar, Elisa J F, Houwink, Gerard A, Rongen, Ron H N, van Schaik, Jesse J, Swen, Daan, Touw, Jan, van der Weide, Roos, van Westrhenen, Vera H M, Deneer, Arne, Risselada
Publikováno v:
European journal of human genetics : EJHG.
Pharmacogenetics (PGx) studies the effect of heritable genetic variation on drug response. Clinical adoption of PGx has remained limited, despite progress in the field. To promote implementation, the Dutch Pharmacogenetics Working Group (DPWG) develo
Autor:
Karel H. van der Pol, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer-Veger, Anne Marie Buunk, Henk-Jan Guchelaar, Arne Risselada, Ron H. N. van Schaik, Jesse J. Swen, Daan Touw, Jan van der Weide, Roos van Westrhenen, Vera H. M. Deneer, Elisa J. F. Houwink, Gerard A. Rongen
Publikováno v:
European Journal of Human Genetics. Nature Publishing Group
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate PGx implementation by developing evidence-based pharmacogenetics guidelines to optimize pharmacotherapy. This guideline describes the gene-drug interaction of ABCG2 with allopurinol,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6cec37152e6fc9e7daaa1ea1275fd4f
https://hdl.handle.net/1887/3458834
https://hdl.handle.net/1887/3458834
Autor:
Nienke J de Boer-Veger, Roos van Westrhenen, Bianca Soree, Anne-Marie Buunk, Marga Nijenhuis, Hans Mulder, Henk-Jan Guchelaar, Vera H.M. Deneer, Gerard A. Rongen, Jesse J. Swen, Bob Wilffert, Jurriaan M. J. L. Brouwer, Ron H.N. van Schaik, Jan van der Weide, Elisa J. F. Houwink
Publikováno v:
European Journal of Human Genetics, 30, 10, pp. 1114-1120
European Journal of Human Genetics, 30, 1114-1120
European journal of human genetics : EJHG
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics, 30. Nature Publishing Group
European Journal of Human Genetics, 30, 1114-1120. Nature Publishing Group
European Journal of Human Genetics, 30(10). Nature Publishing Group
European Journal of Human Genetics, 30, 1114-1120
European journal of human genetics : EJHG
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics, 30. Nature Publishing Group
European Journal of Human Genetics, 30, 1114-1120. Nature Publishing Group
European Journal of Human Genetics, 30(10). Nature Publishing Group
Contains fulltext : 286842.pdf (Publisher’s version ) (Closed access) The Dutch Pharmacogenetics Working Group (DPWG) guideline presented here, presents the gene-drug interaction between the genes CYP2C19 and CYP2D6 and antidepressants of the selec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::565c0a685f5e344ceb85fd0fd0e5746c
https://hdl.handle.net/1887/3247348
https://hdl.handle.net/1887/3247348
Autor:
Nienke J de Boer-Veger, Vera H.M. Deneer, Ron H.N. van Schaik, Gerard A. Rongen, Jan van der Weide, Henk-Jan Guchelaar, Bob Wilffert, Bianca Soree, Marga Nijenhuis, Hans Mulder, Elisa J. F. Houwink, Maja Matic, Jesse J. Swen, Anne-Marie Buunk
Publikováno v:
European journal of human genetics : EJHG
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics, 30(10). Nature Publishing Group
European Journal of Human Genetics, 30, 1105-1113
European Journal of Human Genetics. Nature Publishing Group
European Journal of Human Genetics, 30, 10, pp. 1105-1113
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics, 30(10). Nature Publishing Group
European Journal of Human Genetics, 30, 1105-1113
European Journal of Human Genetics. Nature Publishing Group
European Journal of Human Genetics, 30, 10, pp. 1105-1113
Contains fulltext : 286843.pdf (Publisher’s version ) (Closed access) The current Dutch Pharmacogenetics Working Group (DPWG) guideline, describes the gene-drug interaction between CYP2D6 and the opioids codeine, tramadol and oxycodone. CYP2D6 geno